Anxiolytic and antidepressant effects of a leaf extract of Palisota hirsuta K. Schum. (Commelinaceae) in mice

International Journal of Pharmacology

Volumn 6, Issue 1, 2010, Pages 1-17

  Woode, Eric ^a   Boakye Gyasi, E ^a   Amidu, N ^a   Ansah, C ^a   Duwiejua, M ^a  

^a KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

Author keywords

Antidepressants; Anxiolytic; Mice; Palisota hirsuta

Indexed keywords

ALCOHOL; FLUMAZENIL; FLUOXETINE; IMIPRAMINE; METHYLDOPA; PLANT EXTRACT; RESERPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; COMMELINACEAE; CONTROLLED STUDY; DARK ADAPTATION; DEPRESSION; DOSE RESPONSE; FORCED SWIMMING TEST; LIGHT ADAPTATION; MAZE TEST; MOTOR PERFORMANCE; MOUSE; NONHUMAN; OPEN FIELD TEST; PLANT LEAF; TRANQUILIZING ACTIVITY;

EID: 75749142631     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2010.1.17     Document Type: Article

References (65)

1. Abbiw, D.K., 1990. Useful Plants of Ghana. 1st Edn., Intermediate Technology Publications and Royal Botanic Gardens Kew, London, ISBN: 1-85339-043-7.
2. Belzung, C. and G. Le Pape, 1994. Comparison of different behavioral test situations used in psychopharmacology for measurement of anxiety. Physiol. Behav., 56: 623-628.
3. Belzung, C., R. Misslin, E. Vogel, R.H. Dodd and G. Chapouthier, 1987. Anxiogenic effects of methyl-beta-carboline-3-carboxylate in a light/dark choice situation. Pharmacol. Biochem. Behav., 28: 29-33.
4. Bhattacharya, S.K. and S.K. Mitra, 1991. Anxiolytic activity of panax ginseng roots: An experimental study. J. Ethnopharmacol., 34: 87-92.
5. Borsini, F. and A. Meli, 1988. Is the forced swimming test a suitable model tor revealing antidepressant activity? Psychopharmacology, 94: 147-160.
6. Buller, R. and V. Legrand, 2001. Novel treatments for anxiety and depression: Hurdles in bringing them to the market. Drug Discov. Today, 6: 1220-1230.
7. Burkill, H.M., 1985. The Flora of West Tropical Africa. 2nd Edn., Kew. Royal Botanic Gardens, London, ISBN: 1-90034-713-X.
8. Chaouloff, F., M. Durand and P. Mormede, 1997. Anxicty-and activity-related effects of diazepam and chlordiazepoxide in the rat light/dark and dark/light tests. Behav. Brain Res., 85: 27-35.
9. Choleris, E., A.W. Thomas, M. Kavaliers and F.S. Prato, 2001. A detailed ethological analysis of the mouse open field test: Effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field. Neurosci. Biobehav. Rev., 25: 235-260.
10. Costall, B., C.A. Hendrie, M.E. Kelly and R.J. Naylor, 1987. Actions of sulpiride and tiapride in a simple model of anxiety in mice. Neuropharmacology, 26: 195-200.
11. Costall, B.. B.J. Jones, M.E. Kelly, R.J. Naylor, N.R. Oakley, E.S. Onaivi and M.B. Tyers, 1989. The effects of ondansetron (GR38032F) in rats and mice treated subchronically with diazepam. Pharmacol. Biochem. Behav., 34: 769-778.
12. Crawley, J.N., 1981. Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines. Pharmacol. Biochem. Behav., 15: 695-699.
13. Crawley, J.N., J.K. Belknap, A. Collins, J.C. Crabbe, W. Frankel and N. Henderson et al., 1997. Behavioral phenotypes of inbred mouse strains: Implications and recommendations for molecular studies. Psychopmacology, 132: 107-124.
14. Crawley, J.N., 1999. Behavioral phenotyping of transgenic and knockout mice: Experimental design and evaluation of general health, sensory functions, motor abilities and specific behavioral tests. Brain Res., 835: 18-26.
15. Cryan, J.F., O.F. O'Leary, S.H. Jin, J.C. Friedland and M. Ouyang et al., 2004. Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors. Proc. Natl. Acad. Sci. USA., 101: 1886-1891.
16. Cryan, J.F., C. Mombereau and A. Vassout, 2005. The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in mice. Neurosci. Biobehav. Rev., 29: 571-625.
17. Dalvi, A. and I. Lucki, 1999. Murine models of depression. Psychopharmacol. (Berl.), 147: 14-16.
18. Dawson, G.R. and M.D. Tricklebank, 1995. Use of the elevated plus maze in the search for novel anxiolytic agents. Trends Pharmacol. Sci., 16: 33-36.
19. DeMuth, G.W. and S.H. Ackerman, 1983. Alpha-Methyldopa and depression: A clinical study and review of the literature. Am. J. Psychiatry, 140: 534-538.
20. Decker, M.W. and J.L. McGaugh, 1991. The role of interactions between the cholinergic system and other neuromodulatory systems in learning and memory. Synapse, 7: 151-168.
21. Dokosi, O.B., 1998. Herbs of Ghana. Ghana Universities Press, Accra, Ghana, pp: 746.
22. Erdogan, F., A. Golgeli, F. Arman and A.O. Ersoy, 2004. The effects of pentylenetetrazole-induced status epilepticus on behavior, emotional memory and learning in rats. Epilepsy Behav., 5: 388-393.
23. Fukui, M., R.M. Rodriguiz, J. Zhou, S.X. Jiang and L.E. Phillips et al., 2007. Vmat2 heterozygous mutant mice display a depressive-like phenotype. J. Neurosci., 27: 10520-10529.
24. Handley, S.L. and S. Mithani, 1984. Effects of alpha-adrenoceptor agonists and antagonists in a maze exploration model for fear-motivated behavior. Nauny Shmiedebergs Arch. Pharmacol., 327: 1-5.
25. Helton, D.R., J.P. Tizzano, J.A. Monn, D.D. Schoepp and M.J. Kallman, 1998. Anxiolytic and side-effect profile of LY354740: A potent, highly selective, orally active agonist for group II metabotropic glutamate receptors. J. Pharmacol. Exp. Ther., 284: 651-660.
26. Imaizumi, M. and K. Onodera, 2000. Animal models of anxiety. Nippon Yakurigaku Zasshi, 115: 5-12.
27. Iversen, L., 2006. Neurotransmitter transporters and their impact on the development of psychopharmacology. Br. J. Pharmacol., 147: S82-S88.
28. Ji, J., J.L. McDermott and D.E. Dluzen, 2007 Sex differences in K+-evoked striatal dopamine output from superfused striatal tissue fragments of reserpine-treated CD-1 mice. J. Neuroendocrinol. 19: 725-731.
29. Jung, M.E., C.J. Wallis, M.B. Gatch and H. Lal, 2000. Abecarnil and alprazolam reverse anxiety-like behaviors induced by ethanol withdrawal. Alcohol, 21: 161-168.
30. Kasture, V.S., V.K. Deshmukh and C.T. Chopde, 2002. Anxiolytic and anticonvulsive activity of Sesbania grandiflora leaves in experimental animals. Phytother. Res., 16: 455-460.
31. Lepicard, E.M., C. Joubert, I. Hagneau, F. Perez-Diaz and G. Chapouthier, 2000. Differences in anxiety-related behavior and response to diazepam in BALB/cByl and C57BL/6J strains of mice. Pharmacol. Biochem. Behav., 67: 739-748.
32. Lister, R., 1987. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology, 92: 180-185.
33. Maj, J., M. Dziedzicka-Wasylewska, R. Rogoz and Z. Rogoz, 1998. Effect of antidepressant drugs administered repeatedly on the dopamine D3 receptors in the rat brain. Eur. J. Pharmacol., 351: 31-37.
34. Mechan, A.D., P.M. Moran, M. Elliott, A.J. Young, M.H. Joseph and R. Green, 2002. A comparison between Dark Agouti and Sprague-Dawley rats in their behaviour on the elevated plus-maze, open-field apparatus and activity meters and their response to diazepam. Psychopharmacology, 159: 188-195.
35. Metzger, R.R., J.M. Brown, V. Sandoval, K.S. Rau and M.A. Elwan et al., 2002. Inhibitory effect of reserpine on dopamine transporter function. Eur. J. Pharmacol., 456: 39-43.
36. Millan, M.J., F. Lejeune and A. Gobert, 2000. Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: Relevance to the actions of antidepressant agents. J. Psychopharmacol., 14: 114-138.
37. Miller, J.R., 2003. GraphPad Version 4.0. Step-by-Step Examples. 1st Edn., GraphPad Software Inc., San Diego, CA.
38. Moser, P.C., 1989. An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone. Psychopharmacol. (Berl.), 99: 48-53.
39. Motulsky, H.J. and A. Christopoulos, 2003. Fitting model to biological data using linear and nonlinear regression. A Practical Guide to Curve Fitting. San Diego, CA. GraphPad Software Inc. http://www.graphpad.com/manuals/Prism4/ Regress ionBook.pdf.
40. O'Leary, O.F., A.J. Bechtholt, J.J. Crowley, T.E. Hill, M.E. Page and I. Lucki, 2007. Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test. Psychopharmacol. (Berl.), 192: 357-371.
41. Pellow, S., P. Chopin, S.E. File and M. Briley, 1985. Validation of open: Closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods, 14: 149-167.
42. Pellow, S. and S.E. File, 1986. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: A novel test of anxiety in the rat. Pharmacol. Biochem. Behav., 24: 525-529.
43. Perrault, G., E. Morel, B. Zivkovic and D.J. Sanger, 1992. Activity of litoxetine and other serotonin uptake inhibitors in the tail suspension test in mice. Pharmacol. Biochem. Behav., 42: 45-47.
44. Pich, E.M. and R. Samanin, 1986. Disinhibitory effects of buspirone and low doses of sulpiride and haloperidol in two experimental anxiety models in rats: Possible role of dopamine. Psychopharmacology, 89: 125-130.
45. Porsoll, R.D., M. Le-Pichon and M. Jalfre, 1977. Depression: A new animal model sensitive to antidepressant treatments. Nature, 266: 730-732.
46. Porsolt, R.D., G. Anton, N. Blavet and M. Jalfre, 1978. Behavioural despair in rats: A new model sensitive to antidepressant treatments. Eur. J. Pharmacol., 47: 379-391.
47. Porsolt, R.D., G. Brossard, C. Hautbois and S. Roux, 2001. Rodent models of depression: Forced swimming and tail suspension behavioral despair tests in rats and mice. Curr. Protoc. Neurosci., Chapter 8: 8.10A-8.10A.
48. Prut, L. and C. Belzung. 2003. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: A review. Eur. J. Pharmacol., 463: 3-33.
49. Ripoll, N., D.J. David, E. Dailly, M. Hascoet and M. Bourin, 2003. Antidepressant-like effects in various mice strains in the tail suspension test. Behav. Brain Res., 143: 193-200.
50. Rodgers, R.J. and N.J. Johnson, 1995. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety, Pharmacol. Biochem. Behav., 52: 297-303.
51. Rodgers, R.J., B.J. Cao, A. Dalvi and A. Holmes, 1997. Animal models of anxiety: An ethological perspective. Braz. J. Med. Biol. Res., 30: 289-304.
52. Rogoz, Z., A. Wrobel, D. Dlaboga and M. Dziedzicka-Wasylewska, 2002a. Effect of repeated treatment with mirlazapine on the central dopaminergic D2/D3 receptors. Pol. J. Pharmacol., 54: 381-389.
53. Rogoz, Z., W. Margas, G. Skuza, J. Solich, M. Kusmider and M. Dziedzicka-Wasylewska. 2002b. Effect of repeated treatment with reboxetine on the central alpha 1-adrenergic and dopaminergic receptors. Pol. J. Pharmacol., 53: 105-116.
54. Rogoz, Z., G. Skuza and A. Kllodzinska, 2004. Anxiolytic and antidepressant like effects of 7-OH-DPAT, preferental dopamine D3 receptor agonist, in rats. Pol. J. Pharmacol., 56: 519-526.
55. Rowlett, J.K., W. Tornatzky, J.M. Cook, C. Ma and K.A. Miczek, 2001. Zolpidem, triazolam and diazepam decrease distress vocalizations in mouse pups: Differential antagonism by flumazenil and beta-Carboline-3-carboxylate-1-butyl ester (beta-CCt). J. Pharmacol. Exp. Ther., 297: 247-253.
56. Salamone, J.D., 1994. The involvement of nucleus accumbens dopamine in appetitive and aversive motivation. Behav. Brain Res., 61: 117-133.
57. Schinelli, S., M, Paolillo, M. Quartieri and G. Santagostino, 1993. Dopamine synthesis, uptake and metabolism in embryonic rat mesencephalic cultures. Pharmacol. Res., 28: 265-276.
58. Steru, L., R. Chermat, B. Thierry and P, Simon, 1985. The tail suspension test: A new method for screening antidepressants in mice. Psychopharmacol. (Berl.), 85: 367-370.
59. Steru, L., R. Chermat, B. Thierry, J.A. Mico and A. Lenegre et al., 1987. The automated tail suspension test: A computerized device which differentiates psychotropic drugs. Prog. Neuropsychopharmacol. Biol. Psychiatry, 11: 659-671.
60. Teste, J.F., I. Martin and P. Rinjard, 1990. Electrotherapy in mice: Dopaminergic and noradrenergic effects in the tail suspension test. Fundam. Clin. Pharmacol., 4: 39-47.
61. Trease, G.E. and W.C. Evans, 1989. A Textbook of Pharmacognosy. 13th Edn., Bailliere Tindall Ltd., London, ISBN: 0702013617.
62. Van Giersbergen, P.L., E. van Duinkerken, C.G. Sweep, V.M. Wiegant, J.M. van Ree and W. De Jong, 1990. Alpha-methyl dopa induces a naltrexone-insensitive antinociception and hypomotility in rats. Br. J. Pharmacol., 99: 467-472.
63. Woode, E., E, Boakye-Gyasi, G.K. Ainooson, C. Ansah and M. Duwiejua, 2009, Anti-nociceptive effects and the mechanism of Palisota hirsata K. Schum. Leaf extract in murine models. Int. J. Pharmacol., 5: 101-113.
64. Young, R. and D.N. Johnson, 1991. A fully automated light/dark apparatus useful for comparing anxiolytic agents. Pharmacol. Biochem. Behav., 40: 739-743.
65. Zhang, Z.J., 2004. Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders. Life Sci., 75: 1659-1699.